Drugs / Gallium 68 Macro-aggregated albumin
Gallium 68 Macro-aggregated albumin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04243824 | May 2021 → May 2022 | benign prostatic hyperplasia | University of North Carolina, Chapel Hill | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gallium 68 Macro-aggregated albumin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04243824 ↗ |
| Modality | Diagnostic / imaging agent | “The radiotracer, Ga-68 MAA, will be administered prior to PET/MRI scan.” NCT04243824 ↗ |